换一批
换一批Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.
第一作者：
Robert J,Motzer
第一单位：
Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. motzerr@mskcc.org
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);癌, 肾细胞(Carcinoma, Renal Cell);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);吡咯类(Pyrroles);生活质量(Quality of Life);受体, 血小板源生长因子(Receptors, Platelet-Derived Growth Factor);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor)
DOI
10.1200/JCO.2005.02.2574
PMID
16330672
发布时间
2024-12-19
- 浏览127
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
